CLVS

Clovis Oncology, Inc.
CLVS

Overview Fund Activity
Delisted

CLVS was delisted on the 20th of December, 2022.

Back to rankings

271 hedge funds and large institutions have $4.57B invested in Clovis Oncology, Inc. in 2017 Q2 according to their latest regulatory filings, with 73 funds opening new positions, 109 increasing their positions, 72 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
271
Holders Change
+42
Holders Change %
+18.34%
% of All Funds
6.77%
Holding in Top 10
16
Holding in Top 10 Change
+8
Holding in Top 10 Change %
+100%
% of All Funds
0.4%
New
73
Increased
109
Reduced
72
Closed
31
Calls
$300M
Puts
$156M
Net Calls
+$145M
Net Calls Change
+$118M

Top Buyers

1
O
1
OrbiMed
New York
$197M
2
T. Rowe Price Associates
2
T. Rowe Price Associates
Maryland
$190M
3
Jennison Associates
3
Jennison Associates
New York
$111M
4
Franklin Resources
4
Franklin Resources
California
$156M
5
EAM
5
Eagle Asset Management
Florida
$58.2M

Top Sellers

1
Wellington Management Group
1
Wellington Management Group
Massachusetts
$0
2
CCM
2
Consonance Capital Management
New York
$51M
3
Balyasny Asset Management
3
Balyasny Asset Management
Illinois
$41.8M
4
PHS
4
PFM Health Sciences
California
$34.7M
5
PAI
5
Palo Alto Investors
California
$312M
Name Holding Trade Value Shares
Change 		Shares
Change %
BC
26
Boxer Capital
California
$46.8M -$46.8M -500,000 -50%
TA
27
Teachers Advisors
New York
$44M -$2.02M -21,522 -4%
Balyasny Asset Management
28
Balyasny Asset Management
Illinois
$41.8M -$60.7M -648,420 -59%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$39.9M +$3.5M +37,390 +10%
Ameriprise
30
Ameriprise
Minnesota
$39.2M +$6.64M +70,927 +20%
Invesco
31
Invesco
Georgia
$38.5M -$1.55M -16,540 -4%
Goldman Sachs
32
Goldman Sachs
New York
$35.7M -$22.4M -239,151 -39%
PHS
33
PFM Health Sciences
California
$34.7M -$59.6M -636,331 -63%
Two Sigma Investments
34
Two Sigma Investments
New York
$34M -$18.1M -192,854 -35%
Macquarie Group
35
Macquarie Group
Australia
$31.6M +$31.6M +337,669 New
Renaissance Technologies
36
Renaissance Technologies
New York
$30.5M +$16.2M +172,800 +113%
TCIM
37
TIAA CREF Investment Management
New York
$29.9M +$461K +4,925 +2%
Westfield Capital Management
38
Westfield Capital Management
Massachusetts
$29.5M -$5.65M -60,360 -16%
Deutsche Bank
39
Deutsche Bank
Germany
$28.3M +$5.93M +63,307 +26%
Citigroup
40
Citigroup
New York
$26.9M -$13M -139,156 -33%
UBS AM
41
UBS AM
Illinois
$26.6M +$1.16M +12,389 +5%
EA
42
Emerald Advisers
Pennsylvania
$23.8M +$2.48M +26,453 +12%
HM
43
HealthCor Management
New York
$23.1M -$5.03M -53,700 -18%
Voloridge Investment Management
44
Voloridge Investment Management
Florida
$22.2M -$6.09M -65,058 -21%
Wells Fargo
45
Wells Fargo
California
$21.7M -$4.18M -44,628 -16%
RSCM
46
Rock Springs Capital Management
Maryland
$21.7M +$4.4M +47,000 +25%
CWG
47
C WorldWide Group
Denmark
$20.9M -$8.02M -85,609 -28%
Janus Henderson Group
48
Janus Henderson Group
United Kingdom
$20.3M +$20.3M +217,205 New
EMFAT
49
Emerald Mutual Fund Advisers Trust
Pennsylvania
$19.3M +$7.29M +77,810 +61%
VOYA Investment Management
50
VOYA Investment Management
Georgia
$18.3M +$937K +10,008 +5%
1
2
3 4 5